EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway
Prostate cancer (PCa) represents a substantial global health concern and a prominent contributor to male cancer-related mortality. The aim of this study is to explore the role of B-type endothelin receptor (EDNRB) in PCa and evaluate its therapeutic potential. The investigation employed predictive m...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
De Gruyter
2024-01-01
|
| Sarja: | Open Medicine |
| Aiheet: | |
| Linkit: | https://doi.org/10.1515/med-2023-0875 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|